Optiscan Imaging Limited (ASX: OIL) - Share Price

- Current share price for OIL : $0.160

Optiscan Imaging Ltd (OIL) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a commercial stage medical technology company creating a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It developed and manufactured miniaturised digital endomicroscopes with spatial resolution of more than 1000x that of medical CT and MRI.

OIL General Information ⁺

ASX Code	OIL
Website	http://www.optiscan.com
Industry/Sector	Health Care Equipment
Market Cap ($M)	167
OIL Share Price	$0.160
Day High	$0.160
Day Low	$0.150
Last Close	$0.160
OIL Share Price Movement	- ( No change )

Prices as at 16:40, 3 Nov 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Optiscan Imaging Limited (OIL) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Optiscan Imaging Limited (OIL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Optiscan Imaging Limited (OIL) price-sensitive announcements

OIL - Quarterly Activities/Appendix 4C Cash Flow Report

Optiscan Imaging Ltd’s Appendix 4C Quarterly Activities and Cashflow Report for the quarte

Optiscan Imaging Limited (OIL)
30 Oct 2026 | 8:57 AM

OIL - Optiscan Lodges U.S. FDA 510(k) Submission for InVue

Optiscan Imaging Ltd announced on 5 October 2026 that it had lodged a U.S. FDA 510(k) appl

Optiscan Imaging Limited (OIL)
5 Oct 2026 | 9:13 AM

OIL - Optiscan Lodges U.S. FDA 510(k) Submission for InForm

Optiscan Imaging Ltd announced that it has lodged a U.S. FDA 510(k) submission for its InF

Optiscan Imaging Limited (OIL)
1 Oct 2026 | 2:42 PM

OIL - Significant Milestone Reached in ACL Digital Pathology Study

Optiscan Imaging Ltd announced that its live digital pathology study with Australian Clini

Optiscan Imaging Limited (OIL)
10 Sep 2026 | 8:48 AM

Optiscan Imaging Limited (OIL) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Notification of cessation of securities - OIL	4 Nov 2026 8:28AM	$0.160	$0.160	fallen by 0%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Quarterly Activities/Appendix 4C Cash Flow Report	30 Oct 2026 8:57AM	$0.150	$0.160	risen by 6.67%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Optiscan Lodges U.S. FDA 510(k) Submission for InVue	5 Oct 2026 9:13AM	$0.165	$0.160	fallen by 3.03%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Optiscan Lodges U.S. FDA 510(k) Submission for InForm	1 Oct 2026 2:42PM	$0.135	$0.160	risen by 18.52%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Change of Director's Interest Notice	16 Sep 2026 9:04AM	$0.145	$0.160	risen by 10.34%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$167	Notification of cessation of securities - OIL	16 Sep 2026 8:26AM	$0.145	$0.160	risen by 10.34%

OIL Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$6.99	-$0.70	-6.70%	0.00%	0.0%
2025A	-$6.31	-$0.80	2.70%	0.00%	0.0%
2024A	-$6.06	-$0.70	5.80%	0.00%	0.0%

OIL Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Cochlear Limited (COH)	$9,232M	-0.3136	0.2540	0.0785	34.3664	27.4055	25.4109	2.44%	2.54%	2.76%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$21,642M	0.1388	0.1434	0.1574	55.6328	48.6576	42.0409	1.18%	1.27%	1.41%
Imricor Medical Systems Inc (IMR)	$466M	-0.4254	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Optiscan Imaging Limited (OIL)	$157M	-0.0667	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
ResMed Inc. (RMD)	$19,076M	9.5922	0.1012	0.0991	21.7259	19.7299	17.9516	1.07%	1.16%	1.27%

OIL Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	8.84	0.00
Market	0.30	13.10	1.02	0.74
Sector	0.68	20.20	1.77	2.85

OIL Directors

Name	Position	Start Date
Dr Camile Farah	Chief Executive Officer, Managing Director	6 May 2021
Mr Robert Cooke	Non-Executive Chairman, Non-Executive Director	19 Apr 2021
Mr Ronnie (Ron) Song	Non-Executive Director	10 Feb 2021
Ms Karen Borg	Non-Executive Director	29 Jul 2021
Mr Sean Gardiner	Non-Executive Director	14 Jun 2022

Optiscan Imaging Limited (OIL) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
9 Sep 2026	SONG, Ronnie (Ron)	Issued	Direct Shares	230,502	$0.150	$34,575.300
9 Sep 2026	SONG, Ronnie (Ron)	Exercise	Related Securities	230,502	$0.150	$34,575.300
7 Sep 2026	COOKE, Robert	Issued	Indirect Shares	419,094	$0.150	$62,864.100

See all changes in directors' interest & trades for Optiscan Imaging Limited (OIL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

OIL Management

Name	Position
Darius Ooi	CFO
Elissa Hansen	Company Secretary

OIL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Optiscan Imaging Limited (OIL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
386,404,127 (37.01%)	Peters Investments Pty Ltd
155,109,996 (18.57%)	Orchid Capital Investments Pte Ltd

OIL Calendar of Events

Date	Event
24 August 2027	Report (Annual)
24 August 2027	Report (Prelim)
24 February 2027	Report (Interim)
05 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us